← Back to Search

Mechanistic Interventions for Dissociative Disorders (MIND Trial)

N/A
Recruiting
Led By Greg Siegle, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 6 (post-intervention), 3 months post-intervention, 6 months post-intervention
Awards & highlights

MIND Trial Summary

This trial will test whether different interventions can change the neural networks associated with attentional control and interoceptive awareness in people who have dissociative symptoms from trauma.

Who is the study for?
This trial is for people who feel disconnected from themselves (dissociation) after a traumatic event and score at least 7 on the MDI depersonalization scale. Participants must have experienced significant trauma as defined by DSM-5 criteria and be willing to join the study. Those with severe substance dependence, active psychosis, or serious cognitive issues cannot participate.Check my eligibility
What is being tested?
The study tests if focusing on breathing without distractions or using vibration can influence brain networks related to attention control and body awareness in traumatized individuals with dissociative symptoms. It's conducted at Emory University and University of Pittsburgh.See study design
What are the potential side effects?
Potential side effects are not explicitly mentioned but may include discomfort due to focus exercises or vibrations, emotional distress from recalling traumatic events during assessments, or fatigue from participation.

MIND Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 6 (post-intervention), 3 months post-intervention, 6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 6 (post-intervention), 3 months post-intervention, 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Affective Number Stroop (ANS) Task Performance
Change in Attentional Control Scale (ACS) Score
Change in Change in Life Events Checklist Score
+44 more

MIND Trial Design

4Treatment groups
Experimental Treatment
Group I: Vibration With Breath FocusExperimental Treatment2 Interventions
Participants receiving the vibration with breath focus study intervention.
Group II: VibrationExperimental Treatment1 Intervention
Participants receiving the vibration study intervention.
Group III: Screens FreeExperimental Treatment1 Intervention
Participants receiving the screens free study intervention.
Group IV: Breath FocusExperimental Treatment1 Intervention
Participants receiving the breath focus study intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibration
2016
Completed Phase 2
~750

Find a Location

Who is running the clinical trial?

National Center for Complementary and Integrative Health (NCCIH)NIH
837 Previous Clinical Trials
669,583 Total Patients Enrolled
1 Trials studying Dissociation
24 Patients Enrolled for Dissociation
Emory UniversityLead Sponsor
1,647 Previous Clinical Trials
2,564,441 Total Patients Enrolled
Greg Siegle, PhDPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Breath Focus Clinical Trial Eligibility Overview. Trial Name: NCT04670640 — N/A
Dissociation Research Study Groups: Vibration, Vibration With Breath Focus, Screens Free, Breath Focus
Dissociation Clinical Trial 2023: Breath Focus Highlights & Side Effects. Trial Name: NCT04670640 — N/A
Breath Focus 2023 Treatment Timeline for Medical Study. Trial Name: NCT04670640 — N/A
Dissociation Patient Testimony for trial: Trial Name: NCT04670640 — N/A
~73 spots leftby Jan 2026